Schooner Capital
Venture Capital
Active
Boston, United States
64
40M
39
1.21
19
0.39
9
- Stages of investment
- Areas of investment
Summary
In 1971 was created Schooner Capital, which is appeared as VC. The main department of described VC is located in the Boston. The venture was found in North America in United States.
The current fund was established by Vin Ryan. The overall number of key employees were 2.
The higher amount of exits for fund were in 2018. The fund is constantly included in 2-6 investment rounds annually. The top activity for fund was in 2016. Despite it in 2019 the fund had an activity. Speaking about the real fund results, this VC is 26 percentage points more often commits exit comparing to other organizations. This Schooner Capital works on 15 percentage points less the average amount of lead investments comparing to the other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Schooner Capital, startups are often financed by Tribeca Venture Partners, Rainfall Ventures, Lerer Hippeau. The meaningful sponsors for the fund in investment in the same round are Highland Capital Partners, Tribeca Venture Partners, Rainfall Ventures. In the next rounds fund is usually obtained by Highland Capital Partners, Western Technology Investment, VTF Capital.
We can highlight the next thriving fund investment areas, such as Biotechnology, Therapeutics. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. The fund has no exact preference in some founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight Emerald Cloud Lab, Maxwell Health, Commonwealth Fusion.
Investor highlights
- Industry focus
- Stage focus
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 64
- Lead investments
- 19
- Exits
- 9
- Rounds per year
- 1.21
- Follow on index
- 0.39
- Investments by industry
- Health Care (17)
- Biotechnology (15)
- Software (14)
- Information Technology (11)
- Medical (10) Show 73 more
- Investments by region
-
- United States (60)
- United Kingdom (1)
- Canada (1)
- India (1)
- Singapore (1)
- Peak activity year
- 2017
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 12
- Avg. valuation at time of investment
- 13M
- Group Appearance index
- 0.58
- Avg. company exit year
- 15
- Avg. multiplicator
- 2.89
- Strategy success index
- 0.10
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Brand Affinity Technologies | 15 Aug 2008 | Sports, Advertising, Media and Entertainment | Early Stage Venture | 1M | United States, California, Irvine |
Brixton Biosciences | 14 May 2024 | Biotechnology, Information Technology, Life Science | Early Stage Venture | 33M | United States, Massachusetts, Cambridge |
SeLux Diagnostics | 12 Dec 2018 | Health Care, Health Diagnostics | Early Stage Venture | 25M | United States, Massachusetts, Boston |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.